UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR August 2014



Sept. 05, 2014
FirstFridays @ OIP
Speaker:   Terrence Yang
Topic:  "Investor Secrets: What startup investors want...but don't tell you."
Sept. 18, 2014
App Competition - Winners Announced at MMWCON 2014

More Events


UC Logog

UC Reverses Policy on Direct Investments in Startups
The University of California (UC) system has reversed policy that stopped UC campuses from investing directly in their own technology startups. The ban was originally established as part of UC's 1998 Guidelines on University-Industry Relations Policy.

ArmaGen Enters Licensing/Collaboration Deal with Shire

UCLA Startup, ArmaGen, recently announced that it has licensed to Shire the worldwide commercialization rights to its investigational Hunter syndrome drug AGT-182, one of its two lead programs. The deal could net ArmaGen up to $225 million.
UCLA Advanced Materials Event

Save the Date:  UCLA Advanced Materials Partnering Conference | Nov. 5, 2014, 9AM-4PM, UCLA
The conference includes panelists from corporate and venture capital firms, as well as domestic and international regulatory bodies. Startups and inventors from academic institutions across the SoCal region will be in attendance.

Kythera Announces FDA Acceptance of ATX-101 NDA

KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) announced that its New Drug Application (NDA) for ATX-101 (deoxycholic acid) has been accepted for filing by the U.S. Food and Drug Administration (FDA). If approved, ATX-101 will be the first non-surgical treatment for the reduction of submental fat.

Venturing into a New Model - UCLA VC Fund
The UCLA venture capital fund’s distinctive membership structure has shaped its culture to be more of an incubator or club rather than a mostly financial sponsor like the Stanford and Utah funds.

Intellectual Property Announcements

New U.S. Patents Awarded

  • 8,793,618 - Launching of multiple dashboard sets that each correspond to different. . . | N. Martin, et al.
  • 8,791,092 - Molecular tweezers for the treatment of amyloid-related diseases  | S. Frautschy, et al.
  • 8,785,602 - EMP2 antibodies and methods of use thereof for causing regression of a. . . | A. Wu, et al.
  • 8,779,104 - EMP2 antibodies and methods of use thereof causing regression of a. . . | J. Braun, et al.
  • 8,778,608 - CA9 gene single nucleotide polymorphisms predict prognosis and. . . | A. Belldegrun, et al.
  • 8,775,984 - Phase coherent differential structures  | F. Chang, et al.
  • 8,773,964 - CDMA-based crosstalk cancellation for on-chip global high-speed links  | S. Pamarti, et al.
  • 8,772,853 - All graphene flash memory device  | K. Wang, et al.
  • 8,772,041 - Membrane precursors and membranes formed therefrom  | J. Schmidt, et al.
  • 8,766,341 - Epitaxial growth of single crystalline MgO on germanium  | R. Kawakami, et al.
  • 8,765,459 - Apparatus and methods for manipulation and optimization of biological. . . | R. Sun, et al.
  • 8,765,147 - Endophytic fungi from Pteromischum sp. plant, compounds and. . . | D. Teplow, et al.


New UCLA Technologies Available for Licensing



    UCLA Invents - Previous Issue / Archive
    • Fibrocell Science Announces Exclusive License with UCLA
    • UCLA Startup, Kite Pharma, Raises $128M in IPO
    • CytoVale Raises $4.3M Series A for Early Sepsis Detection
    • Inventors and Startup CEOs Share Advice at OIP-ISR Event
    • New UCLA Technologies Available for Licensing
    • Jobs @ UCLA Startups
    • Read Previous Issue | View Newsletter Archive
    UCLA TechMatch Program

    Customized, automated service matches UCLA innovation with
    industry research and technology licensing interests.  Subscribe today.

    UCLA Invents Newsletter, Vol. 2, No. 12

    How to Subscribe

    View Newsletter Archive

    Send editorial comments and corrections to:  
    Bob Nidever, Editor,  bnidever@research.ucla.edu

    Contributors: Neil Bajpayee, Howard Chang, Miles Gerson

    UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
    11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

    Copyright © 2014 The Regents of the University of California. All Rights Reserved.

    Share this